126 related articles for article (PubMed ID: 3682431)
1. Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.
Terazawa A; Tanaka N; Senou N; Inoue F; Matsuura H; Gouchi A; Fuchimoto S; Mimura H; Orita K
Jpn J Surg; 1987 Jul; 17(4):236-42. PubMed ID: 3682431
[TBL] [Abstract][Full Text] [Related]
2. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
4. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
5. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.
Mizutani Y; Okada Y; Yoshida O; Bonavida B
Cancer Biother Radiopharm; 1996 Dec; 11(6):385-91. PubMed ID: 10851499
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
7. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
8. Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells.
Robinson BW; Morstyn G
Cell Immunol; 1987 May; 106(2):215-22. PubMed ID: 3494538
[TBL] [Abstract][Full Text] [Related]
9. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of natural killer cell activity and antibody dependent cell mediated cytotoxicity in pigs.
Yang WC; Schultz RD
Dev Comp Immunol; 1986; 10(3):405-18. PubMed ID: 3464523
[TBL] [Abstract][Full Text] [Related]
11. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
[TBL] [Abstract][Full Text] [Related]
12. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients.
Nakamura H; Ishiguro K; Mori T
Cancer; 1988 Dec; 62(12):2489-97. PubMed ID: 3142676
[TBL] [Abstract][Full Text] [Related]
13. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
14. Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.
Uchida A; Colot M; Micksche M
Br J Cancer; 1984 Jan; 49(1):17-23. PubMed ID: 6691897
[TBL] [Abstract][Full Text] [Related]
15. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
Ramsey KM; Djeu JY; Rook AH
Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
[TBL] [Abstract][Full Text] [Related]
16. Detection of NK activity and antibody-dependent cellular cytotoxicity of lymphocytes by human tumor clonogenic assay--its correlation with the 51Cr-release assay.
Nomori H; Saijo N; Fujita J; Hyoi M; Sasaki Y; Shimizu E; Kanzawa F; Inomata M; Hoshi A
Int J Cancer; 1985 Apr; 35(4):449-55. PubMed ID: 3872846
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of regional lymph node lymphocytes in patients with lung cancer.
Yaita H; Yasumoto K; Nagashima A; Sugimachi K; Nomoto K
J Surg Oncol; 1988 Jul; 38(3):165-72. PubMed ID: 3260643
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor activity of human tumor infiltrating lymphocytes (TIL) and its comparison with peripheral blood lymphocytes (PBL)].
Xu ZY
Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):345-7. PubMed ID: 2177396
[TBL] [Abstract][Full Text] [Related]
19. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
20. Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients.
Konjevic G; Radenkovic S; Srdic T; Jurisic V; Stamatovic Lj; Milovic M
J BUON; 2011; 16(2):219-26. PubMed ID: 21766489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
